TWD 92.9
(-2.31%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 512.49 Million TWD | 37.82% |
2022 | 371.86 Million TWD | 8.79% |
2021 | 341.83 Million TWD | -0.42% |
2020 | 343.27 Million TWD | 12.38% |
2019 | 305.45 Million TWD | 40.81% |
2018 | 216.92 Million TWD | 41.94% |
2017 | 152.83 Million TWD | 20.19% |
2016 | 127.15 Million TWD | -18.27% |
2015 | 155.57 Million TWD | 95.73% |
2014 | 79.48 Million TWD | -31.3% |
2013 | 115.7 Million TWD | -6.07% |
2012 | 123.17 Million TWD | 35.5% |
2011 | 90.9 Million TWD | 293.66% |
2010 | 23.09 Million TWD | 285.93% |
2009 | -12.42 Million TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 152.26 Million TWD | -2.1% |
2024 Q2 | 150.4 Million TWD | -1.22% |
2023 Q1 | 80.6 Million TWD | -29.15% |
2023 FY | 512.49 Million TWD | 37.82% |
2023 Q4 | 155.52 Million TWD | 5.37% |
2023 Q3 | 147.59 Million TWD | 14.63% |
2023 Q2 | 128.76 Million TWD | 59.74% |
2022 FY | 371.86 Million TWD | 8.79% |
2022 Q4 | 113.78 Million TWD | 1.27% |
2022 Q3 | 112.35 Million TWD | 30.7% |
2022 Q2 | 85.96 Million TWD | 43.84% |
2022 Q1 | 59.76 Million TWD | -37.84% |
2021 FY | 341.83 Million TWD | -0.42% |
2021 Q1 | 81.8 Million TWD | -18.72% |
2021 Q2 | 83.31 Million TWD | 1.84% |
2021 Q3 | 80.57 Million TWD | -3.29% |
2021 Q4 | 96.14 Million TWD | 19.33% |
2020 FY | 343.27 Million TWD | 12.38% |
2020 Q1 | 79.25 Million TWD | -19.68% |
2020 Q2 | 73.3 Million TWD | -7.5% |
2020 Q3 | 90.07 Million TWD | 22.87% |
2020 Q4 | 100.64 Million TWD | 11.73% |
2019 Q2 | 67.59 Million TWD | -0.65% |
2019 FY | 305.45 Million TWD | 40.81% |
2019 Q4 | 98.67 Million TWD | 38.67% |
2019 Q3 | 71.15 Million TWD | 5.28% |
2019 Q1 | 68.03 Million TWD | 0.66% |
2018 Q2 | 32.23 Million TWD | -56.54% |
2018 FY | 216.92 Million TWD | 41.94% |
2018 Q3 | 42.92 Million TWD | 33.15% |
2018 Q4 | 67.58 Million TWD | 57.46% |
2018 Q1 | 74.18 Million TWD | 32.97% |
2017 Q3 | 31.33 Million TWD | -22.62% |
2017 FY | 152.83 Million TWD | 20.19% |
2017 Q2 | 40.49 Million TWD | 60.56% |
2017 Q1 | 25.21 Million TWD | -39.98% |
2017 Q4 | 55.78 Million TWD | 78.05% |
2016 Q2 | 25.52 Million TWD | 4.33% |
2016 Q3 | 35.14 Million TWD | 37.69% |
2016 Q4 | 42.01 Million TWD | 19.54% |
2016 FY | 127.15 Million TWD | -18.27% |
2016 Q1 | 24.46 Million TWD | -31.82% |
2015 Q2 | 34.93 Million TWD | -3.5% |
2015 Q4 | 35.88 Million TWD | -26.11% |
2015 FY | 155.57 Million TWD | 95.73% |
2015 Q1 | 36.19 Million TWD | 147.28% |
2015 Q3 | 48.56 Million TWD | 39.02% |
2014 Q2 | 23.78 Million TWD | 21.31% |
2014 FY | 79.48 Million TWD | -31.3% |
2014 Q4 | 14.63 Million TWD | -31.8% |
2014 Q3 | 21.46 Million TWD | -9.74% |
2014 Q1 | 19.6 Million TWD | -38.15% |
2013 Q2 | 27.65 Million TWD | 16.36% |
2013 Q4 | 31.69 Million TWD | -2.71% |
2013 FY | 115.7 Million TWD | -6.07% |
2013 Q1 | 23.77 Million TWD | -50.7% |
2013 Q3 | 32.57 Million TWD | 17.78% |
2012 Q4 | 48.21 Million TWD | 45.58% |
2012 Q3 | 33.12 Million TWD | 40.63% |
2012 Q1 | 18.28 Million TWD | -28.69% |
2012 Q2 | 23.55 Million TWD | 28.82% |
2012 FY | 123.17 Million TWD | 35.5% |
2011 Q3 | 26.84 Million TWD | 0.0% |
2011 FY | 90.9 Million TWD | 293.66% |
2011 Q4 | 25.63 Million TWD | -4.48% |
2011 Q2 | - TWD | 0.0% |
2010 FY | 23.09 Million TWD | 285.93% |
2010 Q4 | - TWD | 0.0% |
2009 FY | -12.42 Million TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Nang Kuang Pharmaceutical Co., Ltd. | 755.56 Million TWD | 32.171% |
Maxigen Biotech Inc. | 424.09 Million TWD | -20.844% |
Bionime Corporation | 715.65 Million TWD | 28.388% |
Pegavision Corporation | 3.57 Billion TWD | 85.649% |
Visco Vision Inc. | 857.15 Million TWD | 40.21% |